Cannabis and schizophrenia;Cannabis et schizophrénie: De l'euphorie à la psychose...

Revue Medicale de Liege

Volumn 59, Issue 2, 2004, Pages 98-103

  Berger, N ^a  

^a NONE

Author keywords

Cannabis; Illicit drugs; Schizophrenia

Indexed keywords

CANNABIS; ILLICIT DRUG;

ADULT; ARTICLE; CANNABIS ADDICTION; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; PREVALENCE; SCHIZOPHRENIA;

HUMANS; MARIJUANA ABUSE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 1842556179     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hall W, Solowij N.- Adverse effects of cannabis. Lancet, 1998, 352, 1611-16.
2. Charles-Nicolas A.- Toxicomanies. Encycl Med Chir, 37-396-A-10.
3. Johns A.- Psychiatric effects of cannabis. Brit J Psychiatry, 2001, 178, 116-122.
4. Bersani G, Orlandi V, Kotzalidis GD, Pancheri P.- Cannabis and schizophrénia: impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatry Clin Neurosci, 2002, 252, 86-92.
5. Zammit S, Allebeck P, Andreasson S, et al.- Self reported cannabis use as a risk factor for schizophrenia in swedish conscripts of 1969: Historical cohort study. Brit Med J, 2002, 325, 1199-1201.
6. Andreasson S, Allebeck P, Rydberg U.- Schizophrenia in users and nonusers of cannabis: A longitudinal study in Stockholm County. Acta Psychiatr Scand, 1989, 79, 505-510.
7. Bühler B, Hambrecht M, Löffler W, et al.- Precipitation and détermination of the onset and course of schizophrenia by substance abuse-a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Res, 2002, 54, 243-251.
8. Allebeck P, Adamsson C, Engström A, Rydberg U.-Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatr Scand, 1993, 88, 21-24.
9. Hambrecht M, Häfner H.- Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust N Z J Psychiatry, 2000, 34, 468-475.
10. Peralta V, Cuesta MJ.- Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand, 1992, 85, 127-130.
11. Mathers DC, Ghodse AH.- Cannabis and Psychotic illness. Brit J Psychiatry, 1992, 161, 648-653.
12. Linszen DH, Dingeman PM, Lenior ME.- Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry, 1994, 51, 273-279.
13. Littrell K, Petty RG, Hilligoss N, et al.- Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat, 2001, 21, 217-221.
14. Conley RR, Kelly DL, Gale EA.- Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse. Schizophr Res, 1998, 33, 95-101.
15. Krystal JH, D'Souza DC, Madonick S, Petrakis IL.-Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophr Res, 1999, 35, S35-S49.
16. Glaser WM.- Olanzapine and the new generation of antipsychotic agents: patterns of use. J Clin Psychiatry, 1997, 58, Suppl 10, 18-21.
17. Berck M, Brook S, Trandafir AI.- A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial. Int Clin Psychopharmacol, 1999, 14, 177-180.
18. Morel A, Herve F, Fontaine B.- Soigner les toxicomanes. Ed Dunod, Paris.